跳至主要内容
临床试验/JPRN-jRCT1080222128
JPRN-jRCT1080222128未知Unknown

Post-marketing surveillance of administration of botulinum toxin type B(NerBloc)-investigation of the clinical condition in patients with changing from botulinum toxin type A (Stydy NB02T)

Eisai Co., Ltd.0 个研究点目标入组 150 人开始时间: 2013年6月28日最近更新:
适应症

试验速览

阶段
Unknown
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • Patient with cervical dystonia who was treated by botulinum toxin type A in the past.
  • Patient who was enrolled in Study NB01S and was evaluated by Toronto Western Spasmodic Torticollis Scale (TWSTRS) at the first injection of NerBloc.

排除标准

  • 未提供

研究者

相似试验